Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Retia 2

K-Number: K180293 · 2018-05-30

ApplicantCentervue S.P.A.
Decision Date2018-05-30
Product CodeMYC
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

Retia 2 is a medical device manufactured by Centervue S.P.A.. It received FDA 510(k) clearance on 2018-05-30 under approval number K180293. The device is classified under product code MYC. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Retia 2?

Retia 2 is a medical device that received FDA 510(k) clearance on 2018-05-30. It is manufactured by Centervue S.P.A.. The 510(k) number is K180293.

When was Retia 2 approved by the FDA?

Retia 2 received FDA 510(k) clearance on 2018-05-30, under approval number K180293.

What company makes Retia 2?

Retia 2 is manufactured by Centervue S.P.A..

What is the FDA product code for Retia 2?

The FDA product code for Retia 2 is MYC.

Other Devices by Centervue S.P.A.

K153181MAIA K180526EIDON FA K192113DRSplus K213705DRSplus K211328EIDON FA, EIDON, EIDON AF, EIDON UWFL K234076iCare ALTIUS CW

View all 8 devices →

Related Devices (Code: MYC)

K153181MAIACentervue S.P.A. K180526EIDON FACentervue S.P.A. K192113DRSplusCentervue S.P.A. K213705DRSplusCentervue S.P.A. K211328EIDON FA, EIDON, EIDON AF, EIDON UWFLCentervue S.P.A. K241931OcuMet Beacon (OCUB100)Ocusciences, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑